The FDA approved Amgen’s cholesterol-lowering drug on Thursday, teeing up a rivalry with a similar treatment that was approved just weeks earlier.
WSJ.com: US Business, Wall Street Journal: Business
Thu, 08/27/2015 - 4:33pm
The FDA approved Amgen’s cholesterol-lowering drug on Thursday, teeing up a rivalry with a similar treatment that was approved just weeks earlier.